<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>The rate of recurrent atrial fibrillation is lowest with amiodarone</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">The rate of recurrent atrial fibrillation is lowest with amiodarone</h1>
<div class="graphic"><div class="figure"><div class="ttl">The rate of recurrent atrial fibrillation is lowest with amiodarone</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">The Canadian Trial of Atrial Fibrillation randomized 403 patients with at least one episode of atrial fibrillation (AF) during the prior six months to low-dose amiodarone, propafenone, or sotalol. After a mean follow-up of 16 months, the likelihood of being free from recurrent AF was highest with amiodarone (65 versus 37 percent for sotalol and propafenone) and the median time to recurrence was longer (&gt;468 versus 98 days).</div><div class="graphic_reference">Data from: Roy D, Talajic M, Dorian P, et al. N Engl J Med 2000; 342:913.</div><div id="graphicVersion">Graphic 69285 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
